                         SEQUENCE LISTING

<110>  The Children's Hospital of Philadelphia
 
<120>  Affinity Peptide-Modified Particles and Targeted Drug Delivery 
       Methods

<130>  RCHP-200WO

<150>  US 61/718,292
<151>  2012-10-25

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant

<400>  1

Gly Pro Arg Pro 
1               


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant

<400>  2

Gly Pro Arg Pro Pro 
1               5   


<210>  3
<211>  54
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant


<220>
<221>  MISC_FEATURE
<222>  (5)..(54)
<223>  Xaa at positions 5-54 may be any naturally-occurring or 
       artificial amino acid and up to 49 of them may be absent

<400>  3

Gly Pro Arg Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Xaa Xaa Xaa Xaa 
    50                  


<210>  4
<211>  55
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant


<220>
<221>  MISC_FEATURE
<222>  (6)..(55)
<223>  Xaa at positions 6-55 may be any naturally-occurring or 
       artificial amino acid and up to 49 of them may be absent

<400>  4

Gly Pro Arg Pro Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
    50                  55  


<210>  5
<211>  55
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant


<220>
<221>  MISC_FEATURE
<222>  (5)..(54)
<223>  Xaa at positions 5-54 may be any naturally-occurring or 
       artificial amino acid and up to fifty of them may be absent

<400>  5

Gly Pro Arg Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Xaa Xaa Xaa Xaa Cys 
    50                  55  


<210>  6
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant


<220>
<221>  MISC_FEATURE
<222>  (6)..(55)
<223>  Xaa at positions 6-55 may be any naturally-occurring or 
       artificial amino acid and up to fifty of them may be absent

<400>  6

Gly Pro Arg Pro Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
    50                  55      


<210>  7
<211>  55
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant


<220>
<221>  MISC_FEATURE
<222>  (5)..(54)
<223>  Xaa at positions 5-54 are Gly and up to 49 of them may be absent

<400>  7

Gly Pro Arg Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Xaa Xaa Xaa Xaa Cys 
    50                  55  


<210>  8
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant


<220>
<221>  MISC_FEATURE
<222>  (6)..(55)
<223>  Xaa at positions 6-55 are Gly and up to 49 of them may be absent

<400>  8

Gly Pro Arg Pro Pro Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
        35                  40                  45              


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys 
    50                  55      


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fibrin-Avid Peptide Variant

<400>  9

Gly Pro Arg Pro Pro Gly Gly Gly Cys 
1               5                   


